Access cutting-edge solid tumors treatment through this clinical trial at a research site in Hinsdale. Study-provided care at no cost to qualified participants.
Access solid tumors specialists in Hinsdale at no cost
This study follows strict safety protocols and ethical guidelines
All study-related solid tumors treatment provided free
The goal of this clinical trial is to define a safe and effective dose of CRB-701 for participants with solid tumors that are expressing a protein called nectin-4. The main questions it aims to answer are: What is the the safe and effective dose of CRB-701 when used alone? What cancers can be treated effectively with CRB-701? Participants will be asked to attend clinic and be given a intravenous infusion of CRB-701 on its own. They will have blood tests and other assessments to measure whethe
Sponsor: Corbus Pharmaceuticals Inc.
Check if you qualify for this solid tumors clinical trial in Hinsdale, IL
If you're searching for solid tumors treatment options in Hinsdale, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hinsdale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.